Quick Takeaways
- TCG Crossover GP II, LLC filed SCHEDULE 13G for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT).
- Disclosed ownership: 10%.
- Date of event: 27 Dec 2024.
TCG Crossover GP II, LLC - 27 Dec 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)
- Filing Manager
- TCG Crossover GP II, LLC
- Reporting Manager
- TCG Crossover GP II, LLC
- Symbol
- RAPT
- Shares outstanding
- 132,063,163 shares
- Disclosed Ownership
- 13,193,110 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Jan 2025, 16:08:01 UTC
- Date of event
- 27 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"TCG Crossover GP II, LLC disclosed 10% ownership in RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT) on 27 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Jan 2025, 16:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 10% | 13,193,110 | 0 | 13,193,110 | /s/ Craig Skaling | Authorized Signatory | |
| TCG Crossover Fund II, L.P. | 10% | 13,193,110 | 13,193,110 | 0 | /s/ Craig Skaling | Authorized Signatory | |
| Chen Yu | 10% | 13,193,110 | 0 | 13,193,110 | /s/ Craig Skaling | By POA as Attorney-in-Fact |